To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Triple reuptake inhibitors
Triple reuptake inhibitors (TRIs) are a relatively new class of antidepressants which are currently undergoing clinical trials for treatment of depression, anxiety disorders and some personality disorders.
Additional recommended knowledge
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Triple_reuptake_inhibitors". A list of authors is available in Wikipedia.|